NAT14 anticorps (AA 5-33) (FITC)

N° du produit ABIN1916138

Détail du produit anti-NAT14 anticorps (FITC)

Antigène: NAT14 (N-Acetyltransferase 14 (GCN5-Related, Putative) (NAT14))

Épitope: AA 5-33

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp NAT14 est conjugé à/à la FITC

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Specificité: This NAT14 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 5-33 amino acids from the N-terminal region of human NAT14.

Purification: Affinity purified

Isotype: IgG

Information d'application

Indications d'application: Approved: ELISA, IHC, WB

Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: PBS, no preservatives added

Agent conservateur: Without preservative

Conseil sur la manipulation: Aliquot to avoid repeated freezing and thawing.

Stock: 4 °C,-20 °C

Stockage commentaire: Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.

Date de péremption: 6 months

Détails sur NAT14

Antigène: NAT14 (N-Acetyltransferase 14 (GCN5-Related, Putative) (NAT14))

Autre désignation: NAT14 (NAT14 Produits)

Synonymes: anticorps BC047219, anticorps KLP1, anticorps N-acetyltransferase 14, anticorps N-acetyltransferase 14 (putative), anticorps Nat14, anticorps NAT14

Sujet: Name/Gene ID: NAT14

Synonyms: NAT14, KLP1, N-acetyltransferase 14

ID gène: 57106

Pathways: SARS-CoV-2 Protein Interactome